Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001072613-09-001282
Filing Date
2009-08-26
Accepted
2009-08-26 16:16:34
Documents
1
Group Members
WORKING OPPORTUNITY FUND (EVCC) LTD.

Document Format Files

Seq Description Document Type Size
1 ONCOGENEX PHARMACEUTICALS, INC. sch13d_16578.htm SC 13D/A 125284
  Complete submission text file 0001072613-09-001282.txt   127326
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Subject) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45969 | Film No.: 091036570
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2600 - 1055 W. GEORGIA STREET VANCOUVER A1 V6E 3R5
Business Address 2600 - 1055 W. GEORGIA STREET VANCOUVER A1 V6E 3R5 604-895-7255
GrowthWorks Capital Ltd. (Filed by) CIK: 0001444153 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13D/A